LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03103087 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 6, 2017
Last Update Posted : November 20, 2018
|
Sponsor:
Myovant Sciences GmbH
Information provided by (Responsible Party):
Myovant Sciences GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | September 30, 2019 |
| Estimated Study Completion Date : | February 28, 2020 |